Generation of iPSC line NCHi012-A from a patient with Alagille syndrome and heterozygous pathogenic variant in the JAG1 gene
Summary
Alagille syndrome (ALGS) is an autosomal dominant disease affecting the liver, heart and other organs with high variability. About 95% of ALGS cases are associated with pathogenic variants in JAG1, encoding the Jagged1 ligand that binds to Notch receptors. The iPSC line NCHi012-A was derived from an ALGS patient with cholestatic liver disease and mild pulmonary stenosis, who is heterozygous for a 2 bp deletion in the JAG1 coding sequence. We report here an initial characterization of NCHi012-A to evaluate its morphology, pluripotency, differentiation potential, genotype, karyotype and identity to the source patient. Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.
Authors | Cunningham D, Stanberry I, Ye S, Alonzo M, Zhao MT, Garg V, Lilly B |
---|---|
Journal | Stem cell research |
Publication Date | 2023 Sep;71:103177 |
PubMed | 37549562 |
PubMed Central | PMC10528323 |
DOI | 10.1016/j.scr.2023.103177 |